POLONELLI, Luciano
 Distribuzione geografica
Continente #
NA - Nord America 9.730
EU - Europa 8.762
AS - Asia 3.414
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 15
SA - Sud America 9
OC - Oceania 6
Totale 21.960
Nazione #
US - Stati Uniti d'America 9.402
CN - Cina 3.049
UA - Ucraina 2.083
IE - Irlanda 1.803
DE - Germania 1.421
SE - Svezia 1.209
FI - Finlandia 1.079
IT - Italia 795
CA - Canada 325
TR - Turchia 194
AT - Austria 121
SG - Singapore 99
GB - Regno Unito 97
FR - Francia 36
BE - Belgio 32
IN - India 29
NL - Olanda 27
EU - Europa 15
AE - Emirati Arabi Uniti 11
ID - Indonesia 11
PL - Polonia 11
EG - Egitto 8
ES - Italia 8
RO - Romania 7
CZ - Repubblica Ceca 6
AL - Albania 5
BR - Brasile 5
IL - Israele 5
ZA - Sudafrica 5
JP - Giappone 4
NG - Nigeria 4
AU - Australia 3
HU - Ungheria 3
LK - Sri Lanka 3
LU - Lussemburgo 3
NZ - Nuova Zelanda 3
RU - Federazione Russa 3
CM - Camerun 2
DZ - Algeria 2
EE - Estonia 2
HK - Hong Kong 2
HR - Croazia 2
MX - Messico 2
PE - Perù 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
BD - Bangladesh 1
BG - Bulgaria 1
CO - Colombia 1
EC - Ecuador 1
IR - Iran 1
MA - Marocco 1
MY - Malesia 1
NO - Norvegia 1
PK - Pakistan 1
PR - Porto Rico 1
RS - Serbia 1
RW - Ruanda 1
SY - Repubblica araba siriana 1
SZ - Regno dello Swaziland 1
TW - Taiwan 1
VN - Vietnam 1
Totale 21.960
Città #
Jacksonville 2.242
Dublin 1.802
Chandler 1.158
Beijing 837
Dearborn 780
Nanjing 644
Ashburn 608
San Mateo 570
Princeton 504
Toronto 303
Des Moines 264
Ann Arbor 245
Bremen 243
Wilmington 215
Shenyang 189
Izmir 182
Kunming 168
Nanchang 164
Hebei 160
Hefei 160
Helsinki 158
Parma 133
Vienna 121
Düsseldorf 103
Grafing 101
New York 101
Jinan 97
Boardman 79
Tianjin 75
Jiaxing 74
Changsha 73
Shanghai 64
Fremont 61
Seattle 57
Woodbridge 52
Guangzhou 51
Norwalk 36
Brussels 30
Houston 30
Hangzhou 28
Milan 24
Rome 23
Singapore 23
Borås 22
Zhengzhou 21
Chengdu 20
Los Angeles 20
Rockville 17
Ningbo 16
Taizhou 15
Wuhan 15
Fuzhou 13
Haikou 12
Taiyuan 12
Wenzhou 12
Reggio Nell'emilia 11
Sharjah 11
Kocaeli 10
Modena 10
Washington 10
Auburn Hills 9
Redwood City 9
Shaoxing 9
Xian 9
Catania 8
Chongqing 8
Amsterdam 7
Baotou 7
Cairo 7
Edinburgh 7
Falls Church 7
Quzhou 7
Radomsko 7
London 6
Lugo 6
Munich 6
Napoli 6
Pune 6
Scottsdale 6
Torino 6
Bari 5
Bologna 5
Centro 5
Fairfield 5
Florence 5
Jakarta 5
Piacenza 5
Redmond 5
Andover 4
Augusta 4
Campi Bisenzio 4
Colli Del Tronto 4
Frankfurt am Main 4
Genova 4
Johannesburg 4
Langfang 4
Makassar 4
Martina Franca 4
Merano 4
Mestre 4
Totale 13.510
Nome #
Il problema dell’antibiogramma nelle infezioni da funghi filamentosi. 140
Antibiocorpi: Anticorpi anti-idiotipo ad attività antibiotica in vivo ed in vitro 126
Caratterizzazione ed isotipizzazione di anticorpi monoclonali murini anti-laminarina con potenziale attività candidacida. 118
Dissecting the structure-function relationship of a fungicidal peptide derived from the constant region of human immunoglobulins 109
Micologia Clinica. Manuale di Laboratorio. 108
L’antibiogramma per i miceti 107
Significato diagnostico delle IgA (secretorie) adese a miceti lievitiformi nel corso delle infezioni orali di pazienti a rischio. 92
Peptides of the Constant Region of Antibodies Display Fungicidal Activity 91
Metabolic profiling of Candida albicans 88
Novel activity of a synthetic decapeptide against Toxoplasma gondii Tachyzoites 84
Antifungal peptides within the antibodies 83
Antifungal properties of newly designed carbonic anhydrases inhibitors selective for microbial enzymes 80
Antibiocorpi: anticorpi anti-idiotipo ad attività antibiotica 78
Antibodies as a source of anti-infective peptides: an update 78
Significato diagnostico di IgA secretorie adese a cellule lievitiformi nelle candidosi orali 78
Antibody-mediated protective immunity in fungal infections 77
Clonaggio e sequenziamento dei geni codificanti per la tossina killer di Pichia anomala 75
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 74
Antibody peptide based antifungal immunotherapy 74
In vitro tests: how do they influence therapeutic choices? 73
Anaflatoxin B1 as the Paradigm of a New Class of Vaccines Based on “Mycotoxoids” 73
Production of an engineered killer peptide in Nicotiana benthamiana by using a Potato virus X expression system 72
Vaccination of lactating dairy cows for the prevention of Aflatoxin B1 carry over in milk 72
Fungicidal activity of peptides encoded by immunoglobulin genes 72
Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation 72
Analisi dell’attività fungicida di un peptide derivato dalla regione costante di immunoglobuline M umane 71
A synthetic peptide as a novel anticryptococcal agent 70
Antibody constant region peptides can display immunomodulatory activity through activation of the Dectin-1 signalling pathway. 70
Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies 70
Antibodies as Crypts of Antiinfective and Antitumor Peptides 69
Involvement of beta-glucans in the wide-spectrum antimicrobial activity of Williopsis saturnus var. mrakii MUCL 41968 killer toxin 69
Natural and synthetic peptides with antifungal activity 69
Peptides from the inside of the antibodies are active against infectious agents and tumours 68
ANTIMICROBIAL EFFECT ON CANDIDA ALBICANS BY DIFFERENT COUPLING OF WAVELENGTHS AND COLORS IN PHOTODYNAMIC PROTOCOLS: IN VITRO AND IN VIVO STUDY 67
Caratterizzazione dell'epitopo polisaccaridico reattivo con IgA secretorie della mannoproteina maggiore da stress secreta da Candida albicans. 67
Conformation-sensitive Antibodies against Alzheimer Amyloid-beta by Immunization with a Thioredoxin-constrained B-cell Epitope Peptide 66
Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs 66
Effect of different wavelengths and dyes on Candida albicans: In vivo study using Galleria mellonella as an experimental model 66
A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities 66
Identificazione di lieviti produttori di tossine killer in vivo 65
Anaerobic yeast killer system. 65
Antibiobodies: antibiotic internal image antibodies 65
Biotyping of pathogenic fungi by the killer system and with monoclonal antibodies. 65
AFM1 in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination 65
Nuovo modello di vaccinazione idiotipica e terapia anti-idiotipica nella candidosi sistemica 64
Therapeutic potential of yeast killer toxin-like antibodies and mimotopes 63
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 63
Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade 63
Metabolic profile of Candida albicans 63
Anticorpi antibiotici antiidiotipo immagini interne di tossine killer. 63
Anti-idiotypic vaccination against group B streptococci 63
Oral and maxillofacial fungal infections 63
Dissection of the Structural Features of a Fungicidal Antibody-Derived Peptide 63
Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis 62
Immagine interna del fenomeno killer dei lieviti 62
Antibody Complementarity-Determining Regions (CDRs): A Bridge between Adaptive and Innate Immunity 62
A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents 62
Biological characterization of Fusapyrone and Deoxyfusapyrone, two bioactive secondary metabolites of Fusarium semitectum 61
Caratterizzazione di mannoproteine da stress di Candida albicans reattive con IgA secretorie 61
A multicenter study of the in vitro activity of voriconazole against 1,996 yeast and 192 mould clinical isolates 61
Antireceptor yeast killer toxin-like antibiobodies 61
Marcatori epidemiologici. 61
Voriconazole activity against clinical yeast isolates: a multicentre Italian study 60
Activity of nitroimidazole derivative synthetic compounds on Trichomonas vaginalis and Candida albicans isolates 60
Caratterizzazione antigenica di Microsporum canis, M. distortum, M. ferrugineum e Trichophyton soudanense. 60
Yeast killer toxins and dimorphism. 60
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 60
AC-1001 H3 CDR peptide induces apoptosis and signs of autophagy in vitro and exhibits antimetastatic activity in a syngeneic melanoma model 60
Antifungal activity of the C-terminal peptide from human serum albumin 60
Selective miRNA down-regulation in the inhibition of HIV-1 replication by a human serum antibody-derived peptide 60
Cases of imported malaria in Parma observed in the period January-September 1994 59
Antibiobodies: antibiotic-like antiidiotypic antibodies. 59
Reversible self-assembly: A key feature for a new class of autodelivering therapeutic peptides 58
Attività in vitro di anticorpi anti-idiotipo di tossine killer di lieviti su microrganismi eucarioti e procarioti 58
Vaccini antiidiotipici ricombinanti attivi nei confronti di infezioni da batteri capsulati. 58
Antimicrobial activity of poultry bone and meat trimmings hydrolyzates in low-sodium turkey food 58
A killer mimotope with therapeutic activity against AIDS-related opportunistic microorganisms inhibits ex vivo HIV-1 replication 58
Mode of action of a killer peptide against Toxoplasma gondii 58
Mycobacterium parmense sp. nov 57
Protective antifungal yeast killer toxin-like antibodies 57
Antibioantibodies: antifungal-like antiidiotipic antibodies 57
Engineered commensal bacteria as delivery systems of anti-infective mucosal protectants 57
Any antibody fragment might exert antifungal activity 57
Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis 57
HIV-1 and its transmembrane protein gp41 bind to different Candida species modulating adhesion 56
Production of yeast killer toxin in experimentally infected animals 56
From Pichia anomala killer toxin through killer antibodies to killer peptides for a comprehensive anti-infective strategy 56
Restriction of Influenza virus multiplication induced by PK peptide treatment 56
Attività in vitro e in vivo nei confronti di Candida albicans di peptidi sintetici progettati in silico 56
Vaccine for the prevention of Aflatoxin B1 carry over in the milk of lactating dairy cows 56
Anticorpi immagini interne di tossine killer 56
Studi preliminari sul significato diagnostico di IgA secretorie adese a miceti lievitiformi nelle infezioni delle mucose 56
Les récepteurs des toxines killer de levure 55
Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes. 55
Meccanismi di resistenza ai farmaci antifungini. 55
Vaccini idiotipici ed antiidiotipici 55
Secrezione di tossina killer di Pichia anomala in presenza di tunicamicina 55
Recombinant Streptococcus gordonii for mucosal delivery of a scFv microbicidal antibody 55
Genomic studies on killer yeasts belonging to the genus Pichia. 55
Candidacidal properties of peptides encoded by immunoglobulin genes 55
Totale 6.770
Categoria #
all - tutte 71.242
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.242


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019380 0 0 0 0 0 0 0 0 0 0 327 53
2019/20206.181 1.098 932 478 53 635 550 755 138 518 425 129 470
2020/20213.015 13 465 401 18 467 32 456 19 581 40 502 21
2021/20222.384 23 6 7 50 83 111 333 458 97 285 95 836
2022/20235.790 940 414 267 308 585 607 48 289 2.149 20 111 52
2023/20241.415 105 189 65 53 189 511 50 100 20 133 0 0
Totale 22.119